Science & Wellness — Learning Hub

HIV-Associated Neurocognitive
Disorder (HAND)

Last reviewed: September 2026

Educational information only — not medical advice. Talk to your healthcare provider about your specific situation.

Forgetting words mid-sentence. Walking into a room and not knowing why. Slowed thinking, difficulty concentrating, mental fog that doesn't lift. HAND affects up to 50% of people living with HIV — including many who are virally suppressed on effective treatment.

For educational purposes only — not medical advice. Always consult your healthcare provider before making any health decisions. Read full disclaimer →
Share Facebook X WhatsApp Text Email LinkedIn Reddit Threads Bluesky
← All Deep Dives

What Is HAND?

HIV-Associated Neurocognitive Disorder — HAND — is an umbrella term for a spectrum of cognitive, behavioral, and motor impairments caused by HIV's effects on the central nervous system1. It ranges from subtle difficulties in thinking and memory that may only be detectable on formal neuropsychological testing, to significant impairment that affects daily functioning and independence.

HAND is not a new phenomenon. In the pre-treatment era, severe HIV dementia — called AIDS Dementia Complex — was a devastating and common complication of advanced HIV disease. Antiretroviral therapy dramatically reduced the incidence of severe dementia10. But it did not eliminate HAND. Milder forms of neurocognitive impairment persist in a substantial proportion of PLHIV even on effective treatment — and the reasons why are still being actively researched.

Estimates of HAND prevalence vary widely depending on the population studied and the diagnostic criteria used, but the broad consensus is that between 30 and 50 percent of PLHIV experience some degree of neurocognitive impairment — making it one of the most common complications of HIV in the treatment era2.

HAND is not about intelligence. It is about what happens when a virus — and the inflammation it causes — gains access to the brain and rewires how it processes, retrieves, and holds information. It is a medical condition, not a personal failing.

Why HAND Happens — Even With an Undetectable Viral Load

One of the most important and most confusing aspects of HAND is that it can occur — and persist — even in people with undetectable blood viral loads on effective ART6. Understanding why requires understanding how HIV interacts with the brain differently than with the rest of the body.

The CNS Reservoir — Why the Brain Is Different

The brain is protected by the blood-brain barrier — a tightly regulated interface that controls what substances can pass from the bloodstream into the central nervous system. This barrier is also a shield for HIV: many antiretroviral medications penetrate it poorly, meaning that even when viral load in the blood is undetectable, HIV can replicate at low levels within the CNS.

HIV infects microglia and macrophages — immune cells that reside in the brain — and uses them as a reservoir. These infected cells release inflammatory cytokines and neurotoxic proteins that damage neurons and disrupt neural circuits even when the virus itself is suppressed in blood3. The result is chronic neuroinflammation that continues long after viral suppression is achieved in the periphery.

This is why HAND is not fully explained by blood viral load, and why achieving undetectable status — while the most important intervention — does not guarantee cognitive preservation.

Additional factors contribute to HAND risk and severity in PLHIV. Age — the interaction between HIV-related neuroinflammation and normal brain aging — is increasingly recognized as a major factor, particularly for long-term survivors5. Cardiovascular risk factors, including hypertension, diabetes, and lipid abnormalities — all more common in PLHIV — independently affect brain health8. Depression, which is highly prevalent in PLHIV and itself impairs cognition, can both mimic and worsen HAND. And the neurotoxicity of some older antiretroviral medications has left lasting effects on long-term survivors.

The Three Stages of HAND

HAND is classified into three stages that represent a spectrum from subtle to severe. Understanding where on that spectrum a person falls matters for prognosis, treatment decisions, and practical accommodations.

Asymptomatic Neurocognitive Impairment (ANI)
Cognitive impairment detectable on formal neuropsychological testing, but not causing noticeable problems in daily life. The person — and often their providers — may not be aware anything is wrong. Prevalence estimated at 33% of PLHIV in some studies. Important to identify because ANI may progress to more significant impairment without intervention.
Mild Neurocognitive Disorder (MND)
Cognitive impairment that causes mild but noticeable interference with daily activities — taking longer to complete tasks, more reliance on lists and reminders, difficulty with complex tasks like finances or planning. The person is aware something has changed. Prevalence estimated at 12% of PLHIV. This is the stage where most people first seek evaluation.
HIV-Associated Dementia (HAD)
Marked cognitive impairment causing significant interference with daily life and independence. Now relatively uncommon in the ART era — most prevalent in people with advanced untreated HIV or treatment failure. Requires comprehensive neurological and psychiatric management and often significant support systems.

What HAND Feels Like — Symptoms to Know

The symptoms of milder HAND — the forms most common in people on effective ART — are often subtle enough that they are dismissed as stress, aging, depression, or simply "brain fog." This is one of the primary reasons HAND goes undiagnosed. Knowing what to watch for — and how to describe it to your provider — is essential.

Common Symptoms of HAND in the ART Era

HAND vs. Depression vs. Normal Aging — Why It Matters

The symptoms of HAND, depression, and normal cognitive aging overlap significantly — and all three are more prevalent in PLHIV. Depression causes cognitive impairment that can closely mimic HAND. Normal aging slows processing speed and affects memory. Distinguishing between these requires formal neuropsychological testing, not a clinical judgment call in a brief appointment. If you are experiencing cognitive symptoms, ask for a formal evaluation rather than accepting "it's just stress" or "it's just aging" without testing.

Getting a HAND Diagnosis

HAND diagnosis requires formal neuropsychological testing — a battery of standardized tests that evaluate multiple cognitive domains including memory, processing speed, executive function, attention, language, and motor function. A single brief cognitive screening test (like the MoCA or Mini-Mental State Exam) is not sufficient to diagnose HAND — these tools were developed for Alzheimer's detection and miss the pattern of impairment characteristic of HIV-related cognitive decline.

The Diagnostic Process

What Helps — Treatment and Management

There is no medication specifically approved for HAND. Management focuses on optimizing ART, addressing contributing factors, and cognitive rehabilitation. The good news is that several of these interventions have meaningful evidence behind them.

Evidence-Based Approaches to HAND Management

Daily Strategies — Living and Working With HAND

Cognitive compensatory strategies — techniques that work around cognitive limitations rather than through them — can dramatically improve daily functioning for people living with HAND. These are not giving up. They are the same tools that elite performers and high-functioning people use when cognitive demands exceed cognitive capacity.

Practical Compensatory Strategies

Florida — Finding HAND Evaluation and Support

🌴 Florida Resources for HAND

University of Miami — HIV Neurology: The University of Miami Miller School of Medicine has one of the strongest HIV neurology programs in the Southeast, with specific expertise in HAND evaluation and management. For PLHIV in South Florida experiencing cognitive symptoms, this is the most specialized resource available.

University of Florida Health — Neurology (Gainesville): UF Health's neurology program has experience with HIV-associated neurological conditions. For PLHIV in North and Central Florida, UF Health or Shands Hospital is a key referral destination for complex neurological presentations.

Ryan White neuropsychology referrals: Ask your Ryan White case manager whether neuropsychological testing is a covered service in your area. Formal HAND evaluation requires neuropsychology — a referral through Ryan White may make it accessible9.

VA Medical Centers (for veterans): Florida's VA system — including the Miami VA, Tampa VA, and Orlando VA — provides neuropsychological testing and HIV neurology services for eligible veterans living with HIV.

Memory and aging programs: Florida's academic medical centers have memory disorder programs — originally designed for Alzheimer's disease — that can also evaluate and support PLHIV with HAND. These programs often have neuropsychology, neurology, social work, and occupational therapy integrated.

Use the RiseUpToHIV Florida Locator to find HIV specialty care near you.

References & Sources

  1. Antinori A, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 2007. neurology.org
  2. Heaton RK, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. Journal of NeuroVirology, 2011.
  3. Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infectious Diseases, 2013. thelancet.com
  4. Letendre S, et al. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Archives of Neurology, 2008.
  5. Valcour V, et al. Age and HIV infection predict cognitive decline in older HIV-infected persons. Neuroepidemiology, 2011.
  6. Cysique LA, Brew BJ. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. Journal of NeuroVirology, 2011.
  7. Dufouil C, et al. Cognitive rehabilitation in HIV. Journal of Neurology, 2020.
  8. Joska JA, et al. Association of HIV infection and antiretroviral therapy with the frailty phenotype. JAIDS, 2020.
  9. HRSA. Ryan White HIV/AIDS Program — Neurological Complications. hrsa.gov
  10. CDC. HIV and the Brain. Centers for Disease Control and Prevention. cdc.gov

For the full list of organizations and studies that inform RiseUpToHIV, visit our Sources page.

Continue Reading
← HIV & Peripheral Neuropathy HIV & Sleep → All Deep Dives → learning-hub.html